NCT02263313View on ClinicalTrials.gov

EGO-COMBO Clinical End-point Extension Study Beyond 36 Months

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Coronary Restenosis
Interventions
OTHER

EGO-COMBO group

Assess the safety and effectiveness of Combo stent

Trial Locations (1)

Unknown

Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02263313 - EGO-COMBO Clinical End-point Extension Study Beyond 36 Months | Biotech Hunter | Biotech Hunter